Rebecca Robbins
Posts
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it...
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.
Lawsuit Challenges Insurance Restrictions on Weight Loss Drugs Like Wegovy
Many employers and government programs won’t cover costly obesity medications. A lawsuit is challenging one such policy.
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.
Kroger Agrees to Pay $1.2 Billion to Settle Opioid Claims
The grocery chain, which did not admit wrongdoing, is the latest company accused of helping to fuel the opioid crisis to announce a settlement.
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion
Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.
Merck Sues Over Medicare Drug-Price Negotiation Law
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea...
F.D.A. Approves Drug for Rare Form of A.L.S.
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.